# atai Life Sciences

backs a broad derivative portfolio including DemeRx's noribogaine, an ibogaine metabolite cleared by the FDA for first-in-human testing as a non-psychoactive, lower-cardiotoxicity alternative to ibogaine,…

Source: https://en.bioecon.ru/companies/atai-life-sciences/
Updated: 2026-08-15

- Country: Germany
- Ticker: ATAI

## Technologies

- [Psychedelic medicine & neuropsychiatric biologics](https://en.bioecon.ru/technology/psychedelic-medicine-neuropsychiatric-biologics/)